Conversely, adiponectin, which enhances energy expenditure, can mitigate colon cancer related to obesity by inhibiting the mammalian target of the rapamycin (mTOR) pathway [36]. The gene discussed is MTOR; the disease is obesity due to melanocortin 4 receptor deficiency.